PEN Penumbra
- 200.955
- -2.575-1.27%
Penumbra News
Insider Sale: EVP, General Counsel & Secretary Johanna Roberts Sells 600 Shares of Penumbra ...
Penumbra(PEN.US) Officer Sells US$124.45K in Common Stock
$Penumbra(PEN.US)$ Officer Roberts Johanna sold 600 shares of common stock on May 13, 2024 at an average price of $207.41 for a total value of $124.45K.Source: Announcement What is statement of change
Penumbra, Inc. (NYSE:PEN) Q1 2024 Earnings Call Transcript
Penumbra Is Maintained at Buy by Canaccord Genuity
Penumbra Is Maintained at Buy by Canaccord Genuity
Penumbra Price Target Cut to $272.00/Share From $284.00 by Canaccord Genuity
Penumbra Price Target Cut to $272.00/Share From $284.00 by Canaccord Genuity
Canaccord Genuity Maintains Buy on Penumbra, Lowers Price Target to $272
Canaccord Genuity analyst Jason Mills maintains Penumbra (NYSE:PEN) with a Buy and lowers the price target from $284 to $272.
Penumbra Is Maintained at Overweight by Piper Sandler
Penumbra Is Maintained at Overweight by Piper Sandler
Penumbra Price Target Cut to $260.00/Share From $290.00 by Piper Sandler
Penumbra Price Target Cut to $260.00/Share From $290.00 by Piper Sandler
Piper Sandler: Maintaining the Penumbra (PEN.US) rating, adjusted from an increase to an increase rating, and the target price was adjusted from $290.00 to $260.00.
Piper Sandler: Maintaining the Penumbra (PEN.US) rating, adjusted from an increase to an increase rating, and the target price was adjusted from $290.00 to $260.00.
Penumbra (PEN) Q1 Earnings Lag Estimates, Margins Expand
Needham: Reiterates that Penumbra (PEN.US) holds the rating.
Needham: Reiterates that Penumbra (PEN.US) holds the rating.
Needham Reiterates Hold on Penumbra
Needham analyst Mike Matson reiterates Penumbra (NYSE:PEN) with a Hold.
Penumbra Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/08/2024 — Needham Reiterates → Hold 04/03/2024 38.1% Piper Sandler $290 → $290 Reiterates Overweight →
Morgan Stanley Cuts Price Target on Penumbra to $235 From $240, Keeps Equalweight Rating
Penumbra (PEN) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $235 to $300.
Buy Rating Affirmed for Penumbra on Strong Q1 Performance and Robust Growth Prospects
Analysts Offer Insights on Healthcare Companies: Surgery Partners (SGRY), Repare Therapeutics (RPTX) and Penumbra (PEN)
Penumbra (PEN) Gets a Buy From Piper Sandler
RBC Capital Keeps Their Buy Rating on Penumbra (PEN)
Buy Rating Affirmed for Penumbra Amid Strong Q1 Revenue and Growth Prospects
Earnings Call Summary | Penumbra(PEN.US) Q1 2024 Earnings Conference
The following is a summary of the Penumbra, Inc. (PEN) Q1 2024 Earnings Call Transcript:Financial Performance:Penumbra's total revenues for Q1 were $278.7 million, marking a year-over-year increase of
Analysis
Price Target
No Data
